These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 14562863
1. Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy. Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV. J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S85-90. PubMed ID: 14562863 [Abstract] [Full Text] [Related]
4. Peripheral blood mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-infected Malawian patients. Kampira E, Dzobo K, Kumwenda J, van Oosterhout JJ, Parker MI, Dandara C. OMICS; 2014 Jul; 18(7):438-45. PubMed ID: 24816082 [Abstract] [Full Text] [Related]
17. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis. Miró O, Villarroya J, Garrabou G, López S, Rodríguez de la Concepción M, Pedrol E, Martínez E, Giralt M, Gatell JM, Cardellach F, Casademont J, Villarroya F. Antivir Ther; 2005 Jul; 10(8):945-51. PubMed ID: 16430200 [Abstract] [Full Text] [Related]
18. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. Miró O, López S, Rodríguez de la Concepción M, Martínez E, Pedrol E, Garrabou G, Giralt M, Cardellach F, Gatell JM, Vilarroya F, Casademont J. J Acquir Immune Defic Syndr; 2004 Dec 15; 37(5):1550-5. PubMed ID: 15577406 [Abstract] [Full Text] [Related]